Serum-free Kappa and serum-free Lambda light chain assays from The Binding Site Inc are fully quantitative and automated on a wide range of analyzers. They are up to 500 times more sensitive than SPE, and enable diagnosis and monitoring of patients who are negative by SPE/IFE. The assays can replace laborious urine tests for detection of Bence Jones Protein, and provide an earlier marker of disease remission. The assays also serve as a more rapid assessment of therapeutic response, a more sensitive marker of residual disease, and an independent prognostic factor for MGUS progression.
     The Binding Site also offers the third edition of the book Serum Free Light Chain Analysis by AR Bradwell, MD, which describes the clinical utility and laboratory applications of the Freelite™ Serum-free Kappa and Lambda assays.

The Binding Site Inc
(800) 633-4484;